SCHEMBL23766626

SCHEMBL23766626

CCC(CO)NC(=O)Oc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.68
FAAH O00519 6/20 0.52
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 3/20 0.49
POLB P06746 2/20 0.49
MIF P14174 1/20 0.49
SLC1A3 P43003 1/20 0.49
GAA P10253 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RAB9A P51151 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 1/20 0.44
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5113566 0.92 CYP1A2 (0.73) CYP1A2FAAHMEN1KMT2AALDH1A1
SCHEMBL28226501 0.86 CYP1A2 (0.66) CYP1A2FAAHMEN1KMT2AALDH1A1
SCHEMBL8692101 0.84 CYP1A2 (0.64) CYP1A2FAAHSLC1A3CYP3A4RAB9A
SCHEMBL28850625 0.84 CYP1A2 (0.53) CYP1A2FAAHMEN1KMT2AALDH1A1
SCHEMBL20901379 0.82 CYP1A2 (0.61) CYP1A2FAAHMEN1KMT2AALDH1A1
SCHEMBL11060563 0.80 CYP1A2 (0.58) CYP1A2FAAHMEN1KMT2AALDH1A1
SCHEMBL5658218 0.80 CYP1A2 (0.59) CYP1A2FAAHMEN1KMT2AALDH1A1
SCHEMBL14338246 0.79 CYP1A2 (0.58) CYP1A2FAAHMEN1KMT2AALDH1A1
SCHEMBL31115930 0.79 CYP1A2 (0.61) CYP1A2FAAHMEN1KMT2AALDH1A1
SCHEMBL8604298 0.79 CYP1A2 (0.57) CYP1A2FAAHMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-28 US disclosed
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-28 US disclosed
US-20210253517-A1 METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253517-A1 METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF SLC6A15, SLC6A19, ALAD CYP1A2 2096/4885FAAH 1522/4885MEN1 2569/4885
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof SLC6A15, SLC6A19, ALAD CYP1A2 2096/4885FAAH 1522/4885MEN1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.